期刊文献+

盆腔根治术后应用低分子右旋糖酐氨基酸预防静脉血栓病 被引量:1

Preventive effect of low molecular weight dextranon and amino acid injection against venous thromboembolism after radical correction of cavitas pelvis
下载PDF
导出
摘要 目的研究妇科盆腔根治术后应用低分子右旋糖酐氨基酸预防静脉血栓病的可行性。方法随机对照研究276例妇科盆腔根治术后有静脉血栓病高危因素的患者,观察预防性应用低分子右旋糖酐氨基酸组及生理盐水对照组有无静脉血栓形成,并分析血常规、凝血酶原时间(PT)、凝血酶时间(TT)、活化的部分凝血酶时间(APTT)、D-二聚体、凝血因子Ⅱ促凝活性、全血黏度等指标。结果手术后,与对照组相比,预防性应用低分子右旋糖酐氨基酸组静脉血栓发生率及D-二聚体、凝血因子Ⅱ促凝活性、全血黏度明显下降(P<0.05),而凝血功能PT、TT、APTT水平无明显延长。结论预防性使用低分子右旋糖酐氨基酸可改善妇科盆腔根治术患者的凝血功能,减少血栓性疾病的发生率,提示应用低分子右旋糖酐氨基酸预防妇科盆腔根治术后静脉血栓病安全有效。
机构地区 解放军
出处 《第二军医大学学报》 CAS CSCD 北大核心 2011年第5期561-563,共3页 Academic Journal of Second Military Medical University
  • 相关文献

参考文献11

  • 1Santoso J T, Evans L,LamDrecht L, Wan J. Deep venous throm bosis in gynecological oncology: incidence and clinical syrup toms study[J]. Eur J Obstet Gynecol Reprod Biol, 2009, 144: 173 -176.
  • 2杨柏柳,张震宇,郭淑丽.妇科手术后预防下肢深静脉血栓形成对患者凝血功能的影响[J].现代妇产科进展,2007,16(4):278-280. 被引量:28
  • 3Gadducci A,Cosio S,Spirito N,Genazzani A R. The periopera-tive management of patients with gynaecological cancer under- going major surgery: a debated clinical challenge[J]. Crit Rev Oncol Hematol, 2010,73 : 126-140.
  • 4Farina J A Jr,Piccinato C E,Campos A D,Rossi M A. Compar- ative study of isovolemic hemodilution with 3% albumin, dex- tran-40, and prophylactic enoxaparin (LMWH) on thrombus formation at venous microanastomosis in rats[J]. Microsurger y,2006,26:456-464.
  • 5Roderick P, Ferris G, Wilson K, Halls H, Jackson D, Collins R, et al. Towards evidence-based guidelines for the prevention of venous thromboembolism: systematic reviews of mechanical methods,oral anticoagulation,dextran and regional anaesthesia as thromboprophylaxis[J]. Health Technol Assess, 2005,9 : iii -iv,ix- x, 1-78.
  • 6Chen L, Revel S, Morris K, Spiller D G, Serpell L C, Adams D J. Low molecular weight gelator-dextran composites[J]. Chem Commun (Camb) ,2010,46: 6738-6740.
  • 7JonesCI,Payne D A, Hayes P D, Naylor A R, Bell P R, Thompson M M,et al. The antithrombotic effect of dextran-40 in man is due to enhanced fibrinolysis in vivo[J]. J Vasc Surg, 2008,48: 715-722.
  • 8Turpie A G, Esmon C. Venous and arterial thrombosis-patho- genesis and the rationale for anticoagulation[J].Thromb Hae- most, 2011,105 : 586-596.
  • 9Abir F, Barkhordarian S, Sumpio B E. Efficacy of dextran solu- tions in vascular surgery[J]. Vasc Endovascular Surg, 2004,38: 483- 491.
  • 10陈建红.低分子右旋糖酐氨基酸致过敏性休克一例[J].华北国防医药,2008,20(1):46-46. 被引量:2

二级参考文献13

  • 1王辰,翟振国.肺血栓栓塞症-深静脉血栓形成的预防策略[J].中国全科医学,2005,8(2):85-87. 被引量:38
  • 2刘学理,崔志坚,薛光运.右旋糖酐40葡萄糖注射液致过敏性休克1例[J].中国临床药学杂志,2005,14(3):190-190. 被引量:11
  • 3刘玉珍,张震宇,郭淑丽,何文,张晓蓉,王淑珍,刘崇东,李金凤,李琳.妇科盆腔手术后下肢深静脉血栓形成的临床研究[J].中华妇产科杂志,2006,41(2):107-110. 被引量:191
  • 4刘玉珍,张震宇,郭淑丽.妇科开腹与腹腔镜手术后下肢静脉血栓形成的临床分析[J].现代妇产科进展,2006,15(8):622-623. 被引量:29
  • 5张签,魏爱英,李彦博.药物不良反应与合理应用[M].济南:山东科学技术出版社,2001:93.
  • 6ENOXACAN Study Group.Efficacy and safety of enoxaparin versus unfractioned heparin for prevention of deep vein thrombosis in elective cancer surgery:a double-blind randomized multicentre trial with veno graphic assessment[J].Br J Surg,1997,84:1099-1103
  • 7Ginzburg E,Cohn SM,Lopez J,et al.Randomized clinical trial of intermittent pneumatic compression and low molecular weight heparin in trauma[J].Br J Surg,2003,90:1338-1344
  • 8Flam E,Berry S,Coyle A,et al.Blood-flow augmentation of intermittent pneumatic compression systems used for prevention of deep vein thrombosis prior to surgery[J].Am J Surg,1996,171:312-315
  • 9Inada K,Koike S,Skirai N,et al.Effects of intermittent pneumatic leg compression for prevention of postoperative deep venous thrombosis with special reference to fibrinolytic activity[J].Am J Surg,1988,155:602-605
  • 10孙定文,王土凡,王功力.药物不良反应[M].2版.北京:人民卫生出版社,1996:109.

共引文献53

同被引文献13

引证文献1

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部